Texas HIV Medication Program – THMP Medication Advisory Committee

Texas began distributing HIV medications in late 1987 as temporary pilot program; the THMP was officially established in 1989 in Senate Bill 959. The statute that created the HIV Medication Advisory Committee is found in Texas Health & Safety Code, Chapter 85, Subchapter K, Sections 85.271 through 85.282. Rules related to this Committee may be found in Texas Administrative Code, Title 25, Part 1, Chapter 98, Subchapter C, Division 2, Rule 98.121. Committee members are appointed by the executive commissioner of the Texas Health and Human Services Commission.

Stay informed about the committee by subscribing to the THMP News bulletin. 

Next Public Meeting

Date and Time: April 8, 2022, 1:30 p.m. CT
Location: John H. Winters Building, Public Hearing Room 125, First Floor, 701 West 51st Street, Austin, TX 78751

This meeting will be webcast. Members of the public may attend the meeting in person at the address above or access a live stream of the meeting at texashhsmeetings.org/HHSWebcast. Select the tab for the Winters Public Hearing Room Live on the date and time for this meeting. Please email Webcasting@hhsc.state.tx.us if you have any problems with the webcasting function.

This meeting will also be conducted via videoconference call in accordance with the requirements of Section 551.127, Government Code. The member of the Committee presiding over the meeting will be physically present at the location specified above.

Attendees who would like to provide public comment should see the Public Comment section below.

1. Call to order, welcome and opening remarks – Frank Rosas, Acting Committee Chair
2. Logistical announcement and roll call – Sallie Allen, Advisory Committee Coordination Office, HHSC
3. Consideration of January 28, 2022, draft meeting minutes – Sallie Allen, Advisory Committee Coordination Office, HHSC
4. Public comment – Sallie Allen, Advisory Committee Coordination Office, HHSC
5. Department of State Health Services (DSHS) Updates – Imelda Garcia, MPH, Associate Commissioner of Laboratory and Infectious Disease Services
   1. Staffing Update
   2. Health Resources and Services Administration’s Clarifications on Ryan White Program Client Eligibility Determination and Recertification Requirements (Policy Clarification Notice 21-02)
   3. Status of Committee Recommendations
      1. Cabenuva Pilot
      2. 90-day fills
      3. Suspended Medications
      4. Pediatric Medications
   4. Changes to the Texas Administrative Code
      1. Standard Deduction
   5. Budget Report
6. THMP Update - Rachel Sanor, THMP Manager
   1. THMP - Projections and Demographic information
   2. Take Charge Texas
   3. Processing of medication orders
   4. Application processing timeline
7. Election of Presiding Officers (vote required) – Sallie Allen, Advisory Committee Coordination Office (HHSC)
8. Sub-Committee Reports
   1. Eligibility – Frank Rosas
   2. Formulary – Frank Rosas
   3. Governance/Data – Nancy Miertschin
9. Proposed changes to Bylaws (vote required) – Sallie Allen, Advisory Committee Coordination Office (HHSC)
10. Review of action items and agenda topics for next meeting – Frank Rosas, Acting Committee Chair
11. Adjourn – Frank Rosas, Acting Committee Chair

Public Comment: DSHS welcomes public comments pertaining to topics related to the Texas HIV Medication Program. Members of the public who would like to provide public comment may choose from the following options:

1. Oral comments provided virtually: Members of the public must pre-register to provide oral comments virtually during the meeting by completing a Public Comment Registration form at texashhsmeetings.org/THMPMAC_PCReg_Apr2022 no later than 5:00 p.m. Wednesday, April 6, 2022. Please mark the correct box on the Public Comment Registration form and provide your name, either the organization you are representing or that you are speaking as a private citizen, and your direct phone number. If you have completed the Public Comment Registration form, you will receive an email the day before the meeting with instructions for providing virtual public comment. Public comment is limited to three minutes. Each speaker providing oral public comments virtually must ensure their face is visible and their voice audible to the other participants while they are speaking. Each speaker must state their name and on whose behalf they are speaking (if anyone). If you pre-register to speak and wish to provide a handout before the meeting, please submit an electronic copy in accessible PDF format that will be distributed by HHS staff to THMP-MAC members and State staff. Handouts are limited to two pages (paper size: 8.5” by 11”, one side only). Handouts must be emailed to Mary.Richards@dshs.texas.gov immediately after pre-registering, but no later than 5:00 p.m. Wednesday, April 6, 2022, and include the name of the person who will be commenting. Do not include health or other confidential information in your comments or handouts. Staff will not read handouts aloud during the meeting, but handouts will be provided to THMP-MAC members and State staff.
2. Written comments: Members of the public may provide written public comments by completing a Public Comment Registration form at texashhsmeetings.org/THMPMAC_PCReg_Apr2022. A member of the public who wishes to provide written public comments must email the comments to Mary.Richards@dshs.texas.gov no later than 5:00 p.m. Wednesday, April 6, 2022. Please include your name and the organization you are representing or that you are speaking as a private citizen. Written comments must be emailed to DSHS immediately after pre-registering and include the name of the person who will be commenting. Written comments are limited to two pages (paper size: 8.5” by 11”, one side only). Do not include health or other confidential information in your comments. Staff will not read written comments aloud during the meeting, but comments will be provided to THMP-MAC members and State staff.
3. Oral comments provided in-person at the meeting location: Members of the public may provide oral public comment during the meeting in person at the meeting location either by pre-registering using the form above or without pre-registering by completing a form at the entrance to the meeting room. Do not include health or other confidential information in your comments.

Note: These procedures may be revised at the discretion of HHSC.

Contact: Questions regarding agenda items, content, or meeting arrangements should be directed to Mary Richards, Pharmacy Coordinator, DSHS, at Mary.Richards@dshs.texas.gov or via phone at 1-800-255-1090.

This meeting is open to the public. No reservations are required, and there is no cost to attend this meeting.

People with disabilities who wish to attend the meeting and require assistive technology or services should contact Mary Richards, at Mary.Richards@dshs.texas.gov, or 800-255-1090 at least 72 hours prior to the meeting so that appropriate arrangements can be made.

Past meetings

Current THMP Medication Advisory Committee Members

Past MAC Meetings

Meeting minutes are made available upon final approval by the Committee members after their next meeting. A Committee member quorum is required in order to approve the minutes at each meeting. Minutes from previous THMP Advisory Committee meetings are available upon request.

Learn more about the THMP Medication Advisory Committee: Mary Richards 1-800-255-1090

THMP homepage | FAQ | Documents | Policies | Pharmacies
Advisory Committee | Medicare | SPAP | Contact Us